> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on User Fee FDA-Sponsor Communications
- URL: https://www.fdaweb.com/meeting-on-user-fee-fda-sponsor-communications/
- Published: 2020-07-21T12:00:00.000Z
- Updated: 2026-09-14T16:21:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147238

*Federal Register* notice: FDA has announced an 8/11 public meeting entitled “Independent Third-Party Assessment of IND FDA-Sponsor Communication Practices in PDUFA VI.” The meeting will include a presentation from an independent third-party contractor about its assessment of FDA-sponsor communications during the IND stage of drug/biologic development in the user fee program. It will also include a series of presentations by, and a panel discussion with, invited regulatory and industry representatives, and an open public comment period. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-07-21/pdf/2020-15729.pdf?ref=fdaweb.com).